Our new company, K2 Therapeutics, is off to the races to develop new antibody drugs that target multipass membrane proteins. We are hiring so check us out! www.k2-tx.com/home#careers

🎉 Congrats to Nate for his awesome preprint! We used deep learning to design phages with complex infectivity and specificity profiles. Big shifts in host targeting come from just a few mutations! Training on multifunctional data enables precise control over protein properties 🧬 tinyurl.com/yc4wtn8h

Congrats to Nathaniel and Sri for their exciting work teaching protein language models to generate beyond what evolution has explored. They introduce Reinforcement Learning from eXperimental Feedback (RLXF) to steer generation toward enhanced and non-natural functions www.biorxiv.org/content/10.1...

🎉Congrats to Chase on her new preprint! She developed OMEGA--a simple method for assembling custom gene panels for as little as $1.50 per gene. Big step forward protein engineering and design!🧬 www.biorxiv.org/content/10.1...

Finally joining social media after all these years!!